Liver Abscesses in Patients Who Have Had a New Coronavirus Infection
Open Access
- 15 April 2024
- journal article
- research article
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 13 (1) , 72-78
Abstract
Aim of study To analyze clinical, laboratory, instrumental and microbiological data in patients with diagnosed liver abscesses who had previously had a new coronavirus infection.Material and methods An analysis of the work carried out with 13 patients who received treatment at the surgical clinic of the Botkin Hospital in the emergency surgical department No. 76 from September 2021 to October 2022 for liver abscesses and previous COVID-19 is presented.Results All presented patients were comprehensively examined. Surgical intervention was performed — transcutaneous drainage of liver abscesses under ultrasound guidance. Positive changes were revealed in the course of complex therapy, including antibacterial (based on the Results of a microbiological study with determination of the sensitivity of the flora to antibacterial drugs), anti-inflammatory, and daily sanitation of the abscess cavity. All patients were discharged for outpatient follow-up treatment in stable, satisfactory condition. Nine patients (69.2%) were discharged with drain under the supervision of clinic doctors. In 5 patients (30.8%) with regression of the abscess cavity, drainage from the abscess cavity was removed before discharge.Conclusion Patients with previous COVID-19 may develop liver abscesses. It is important to conduct thorough diagnostic measures in patients who present with fever and (or) abdominal pain after a coronavirus infection. Further prospective studies are needed, including morphological assessment of liver changes (upon autopsy in case of death).Keywords
This publication has 11 references indexed in Scilit:
- Liver abscess with necrosis in post COVID-19: A case reportAnnals of Medicine & Surgery, 2021
- Gastrointestinal sequelae 90 days after discharge for COVID-19The Lancet Gastroenterology & Hepatology, 2021
- Pathophysiological mechanisms of liver injury in COVID‐19Liver International, 2020
- COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanismsSignal Transduction and Targeted Therapy, 2020
- Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT AngiographyRadiology, 2020
- Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoVInternational Journal of Infectious Diseases, 2020
- COVID‐19 and liver diseaseLiver International, 2020
- Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoVJournal of Infection, 2020
- Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV InfectionbioRxiv, 2020
- Potential for global spread of a novel coronavirus from ChinaJournal of Travel Medicine, 2020